SCHEMBL2292602

SCHEMBL2292602

Cc1cccc(C)c1OCc1cc(OC(=O)Cc2ccccc2)c(OC(=O)Cc2ccccc2)cc1Br

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.58
THRA P10827 3/20 0.46
THRB P10828 3/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
ATM Q13315 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PTGER4 P35408 2/20 0.41
PTGER3 P43115 2/20 0.41
PTGER2 P43116 2/20 0.41
PTGER1 P34995 1/20 0.41
FFAR4 Q5NUL3 1/20 0.40
PTPN1 P18031 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
HPGD P15428 1/20 0.39
UCHL1 P09936 1/20 0.38
USP5 P45974 1/20 0.38
USP4 Q13107 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2294671 0.85 SMN1; SMN2 (0.56) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2293253 0.84 SMN1; SMN2 (0.55) SMN1; SMN2THRATHRBKMT2APOLB
Benzene SCHEMBL2292612 0.84 PTPN1 (0.49) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2295218 0.83 THRA (0.46) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2286474 0.83 PTPN1 (0.50) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2292756 0.76 MAPT (0.44) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2292640 0.74 SMN1; SMN2 (0.54) SMN1; SMN2KMT2AL3MBTL1ATMTDP1
SCHEMBL2294508 0.74 THRA (0.39) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2291283 0.72 THRA (0.40) SMN1; SMN2THRATHRBKMT2APOLB
SCHEMBL2639771 0.72 L3MBTL1 (0.74) SMN1; SMN2KMT2AL3MBTL1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 SMN1; SMN2 3093/4885THRA 3834/4885THRB 4314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.